Innovation beyond COVID-19: A call to action in healthcare’s new world order

The pandemic is laying bare forces that present a moral obligation, alongside tremendous opportunity and formidable challenges, to the healthcare innovation community. Whatever you want to call it—Post-COVIDcare or the “new world order”—it’s time to see clearly and act accordingly.

How industry heavyweights are fighting in the match against COVID-19

Rock Health’s corporate partners are industry leaders in the healthcare ecosystem and beyond—they represent the nation's top health systems, local and national payers, global pharma organizations, and more. We are honored to partner with them every day as they advance the scalable adoption of innovative healthcare technologies, and particularly now, as they throw their energy and talents behind tackling the effects of COVID-19 head on. Here’s how our corporate partners are fighting the COVID-19 pandemic doing what they do best and more.

Amidst a record $3.1B funding in Q1 2020, digital health braces for COVID-19 impact

Digital health venture funding had its strongest start ever in 2020, with a prodigious $3.1B invested across Q1. In February the COVID-19 pandemic hit the US, sending an immediate shock through public markets. The twin crises of a global pandemic and massive economic shifts will rapidly impact all market sectors, including digital health. To assess the scale, direction, and timing of the impact, we surveyed twelve leading healthcare investors between March 16 and March 20, 2020 (and included our own response in the sample). Although the responses paint a somber picture of the emerging funding environment, there is a tangible sense of resolve to not waste this crisis—to leverage digital health solutions to immediately combat the pandemic and build on that momentum to radically reshape the way healthcare is delivered in the US and globally.

How Rock Health portfolio companies are responding to COVID-19

Digital solutions are enabling communication, surveillance, diagnostics, treatment, and expanded capacity when healthcare needs it most. Our portfolio companies have jumped into action—here’s a look at just a few of the ways they’re supporting patients, providers, and researchers during the COVID-19 pandemic.

Podcast: How Consumers Are Navigating The Digital Healthcare Experience

There's Instagram and Instacart—but how close are we to Insta-health? While the healthcare experience is increasingly digital, privacy issues, the changing patient-physician relationship, and differences across population segments paint a more nuanced, complex picture of consumer behavior. And a critical question has yet to be fully answered—what value is flowing back to the patient?

Three things to expect at HIMSS Health 2.0 VentureConnect 2020

In just one month, more than 40,000 leaders from all over the world will make their way to Orlando for HIMSS20, the biggest health IT gathering of the year. Between a keynote on investing from Yankees star Alex Rodriguez and five days of programming, we’re especially excited to get down to the nitty gritty of digital health investing at Health 2.0 VentureConnect on Wednesday, March 11

Overheard at JPM 2020: The issues healthcare enterprise leaders are talking about

It was a whirlwind week with healthcare investors, entrepreneurs, bankers, and enterprise leaders descending on the J.P. Morgan Healthcare Conference. After dozens of startup pitches, networking receptions galore, and hours spent rushing through the streets of San Francisco, we’re grateful for the energy and hustle we felt from the community working to make healthcare massively better.

Podcast: 2020 Vision: A Look Ahead At Digital Health

Across the last decade, digital health has grown from a blip on the radar of investors to a robust sector receiving nearly one in ten venture dollars invested in the United States. In 2019, digital health saw six IPOs and the second-largest funding year on record with $7.4B. What will the future hold?

Charting a path for consumer genomics: Our investment in

Health data is everywhere we look—and much of it lives within our own DNA. When collected and interpreted in the right way, this data has the potential to both predict our individual risk for numerous diseases and drastically impact health at a population level.

In 2019, digital health celebrated six IPOs as venture investment edged off record highs

Across the last decade, digital health has grown from a blip on the radar of investors to a robust sector receiving nearly one in ten venture dollars invested in the United States. In 2019, 359 US digital health startups raised $7.4B from 627 investors. Though six digital health companies entered the public markets in 2019, exits were a somewhat mixed bag, with M&A below trend at 112 deals across 2019. For our complete 2019 Digital Health Market Update, connect with our partnerships team.

Join our mailing list.

The most popular digital health newsletter. Subscribe to the Rock Weekly to be the first to know about our newest reports.